Breaking News

Pharmaron’s UK Gene Therapy CDMO Begins Major Site Expansion

Project will provide a four-fold increase in gene therapy process development and analytical capacity accommodating viral vector, DNA and RNA drug substance.

Pharmaron Beijing Co. announced that their Liverpool, UK based Gene Therapy CDMO has received a grant from the UK Government’s Life Sciences Innovation Manufacturing Fund (LSMIF) to expand its viral vector and DNA manufacturing facilities by more than 8,000 square meters. “I am delighted that we have been awarded this funding from the UK Government,” said Boliang Lou, Chairman and CEO of Pharmaron. “Securing this grant demonstrates UK Government’s support and trust in Pharmaron to continuousl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters